The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126116193 12611619 3 F 201606 20160816 20160801 20160830 EXP US-ACORDA-ACO_126453_2016 ACORDA 35.00 YR F Y 0.00000 20160830 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126116193 12611619 1 PS AMPYRA DALFAMPRIDINE 1 Unknown UNK U U 22250 TABLET
126116193 12611619 2 SS PLEGRIDY PEGINTERFERON BETA-1A 1 UNK U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126116193 12611619 1 Gait disturbance
126116193 12611619 2 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
126116193 12611619 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
126116193 12611619 Abdominal discomfort
126116193 12611619 Anxiety
126116193 12611619 Arthralgia
126116193 12611619 Back injury
126116193 12611619 Chills
126116193 12611619 Dislocation of vertebra
126116193 12611619 Dizziness
126116193 12611619 Dysstasia
126116193 12611619 Eating disorder
126116193 12611619 Fatigue
126116193 12611619 Fear
126116193 12611619 Feeling abnormal
126116193 12611619 Feeling hot
126116193 12611619 Frustration tolerance decreased
126116193 12611619 Gait disturbance
126116193 12611619 Headache
126116193 12611619 Hyperhidrosis
126116193 12611619 Hypokinesia
126116193 12611619 Influenza like illness
126116193 12611619 Injection site erythema
126116193 12611619 Injection site necrosis
126116193 12611619 Injection site pain
126116193 12611619 Irritability
126116193 12611619 Lethargy
126116193 12611619 Migraine
126116193 12611619 Musculoskeletal pain
126116193 12611619 Musculoskeletal stiffness
126116193 12611619 Nervousness
126116193 12611619 Pain
126116193 12611619 Pallor
126116193 12611619 Pruritus
126116193 12611619 Sleep terror
126116193 12611619 Stress
126116193 12611619 Syncope
126116193 12611619 Systemic lupus erythematosus
126116193 12611619 Temperature intolerance
126116193 12611619 Tension
126116193 12611619 Vomiting
126116193 12611619 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found